SCHEMBL9292707

SCHEMBL9292707

CCCCCCCCC(=O)Oc1ccc2cc(C)c(=O)oc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.52
▸ KMT2A Q03164 7/20 0.52
▸ KDM4E B2RXH2 6/20 0.52
▸ GLA P06280 6/20 0.52
▸ GAA P10253 5/20 0.52
▸ MAOB P27338 2/20 0.52
▸ MAOA P21397 1/20 0.52
▸ HPGD P15428 7/20 0.50
▸ HSD17B10 Q99714 4/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ CYP2C19 P33261 1/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ NPC1 O15118 2/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ CRHBP P24387 1/20 0.48
▸ CRHR2 Q13324 1/20 0.48
▸ HSD17B3 P37058 1/20 0.47
▸ MAPT P10636 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1096028 1.00 ALDH1A1 (0.52) ALDH1A1KMT2AKDM4EGLAGAA
SCHEMBL2190565 1.00 ALDH1A1 (0.52) ALDH1A1KMT2AKDM4EGLAGAA
SCHEMBL2186487 1.00 ALDH1A1 (0.52) ALDH1A1KMT2AKDM4EGLAGAA
SCHEMBL3135327 1.00 ALDH1A1 (0.52) ALDH1A1KMT2AKDM4EGLAGAA
SCHEMBL19171940 0.94 MAOA (0.47) ALDH1A1KMT2AKDM4EGLAGAA
SCHEMBL1095793 0.94 MAOA (0.47) ALDH1A1KMT2AKDM4EGLAGAA
SCHEMBL1526869 0.90 KDM4E (0.63) ALDH1A1KMT2AKDM4EGLAGAA
SCHEMBL2714857 0.85 ALDH1A1 (0.60) ALDH1A1KMT2AKDM4EGLAGAA
SCHEMBL19831442 0.84 CA12 (0.63) ALDH1A1KMT2AKDM4EGLAGAA
SCHEMBL1095981 0.84 CA12 (0.63) ALDH1A1KMT2AKDM4EGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0516814-A4 METHOD AND COMPOSITION FOR DETERMINING ANTIMICROBIAL SUSCEPTIBILITY OF THE MAJORITY OF CLINICALLY SIGNIFICANT GRAM POSITIVE ORGANISMS BAXTER DIAGNOSTICS INC (US) 1994-06-01 — — EP disclosed
EP-0516814-A1 METHOD AND COMPOSITION FOR DETERMINING ANTIMICROBIAL SUSCEPTIBILITY OF THE MAJORITY OF CLINICALLY SIGNIFICANT GRAM POSITIVE ORGANISMS. BAXTER DIAGNOSTICS INC (US) 1992-12-09 — — EP disclosed
WO-1992012257-A1 METHOD AND COMPOSITION FOR DETERMINING ANTIMICROBIAL SUSCEPTIBILITY OF THE MAJORITY OF CLINICALLY SIGNIFICANT GRAM POSITIVE ORGANISMS BAXTER DIAGNOSTICS INC. (US) 1992-07-23 — — WO disclosed
Send feedback